{"id":"https://openalex.org/W2005305700","doi":"https://doi.org/10.1210/jc.2006-2388","title":"B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves\u2019 Disease: A Controlled Pilot Study","display_name":"B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves\u2019 Disease: A Controlled Pilot Study","alternate_titles":[],"publication_year":2007,"publication_date":"2007-02-07","ids":{"openalex":"https://openalex.org/W2005305700","doi":"https://doi.org/10.1210/jc.2006-2388","mag":"2005305700","pmid":"https://pubmed.ncbi.nlm.nih.gov/17284622"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2006-2388","doi":"https://doi.org/10.1210/jc.2006-2388","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2006-2388","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005305700"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037480210","display_name":"Daniel El Fassi","orcid":"https://orcid.org/0000-0001-8226-1658","observed_orcids":["https://orcid.org/0000-0001-8226-1658"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801498763"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Daniel El Fassi","raw_affiliation_strings":["Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark","Institute for Inflammation Research (D.E.F., C.H.N.), Rigshospitalet National University Hospital, 2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark","institution_ids":["https://openalex.org/I2801498763"]},{"raw_affiliation_string":"Institute for Inflammation Research (D.E.F., C.H.N.), Rigshospitalet National University Hospital, 2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060399289","display_name":"Claus Henrik Nielsen","orcid":"https://orcid.org/0000-0001-7543-9016","observed_orcids":["https://orcid.org/0000-0001-7543-9016"]},"institutions":[{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Claus H. Nielsen","raw_affiliation_strings":["Institute for Inflammation Research (D.E.F., C.H.N.), Rigshospitalet National University Hospital, 2100 Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Inflammation Research (D.E.F., C.H.N.), Rigshospitalet National University Hospital, 2100 Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072144010","display_name":"Steen Joop Bonnema","orcid":"https://orcid.org/0000-0002-6898-1752","observed_orcids":["https://orcid.org/0000-0002-6898-1752"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801498763"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Steen J. Bonnema","raw_affiliation_strings":["Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark","institution_ids":["https://openalex.org/I2801498763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053726532","display_name":"Hans Carl Hasselbalch","orcid":"https://orcid.org/0000-0003-3936-8032","observed_orcids":["https://orcid.org/0000-0003-3936-8032"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801498763"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hans C. Hasselbalch","raw_affiliation_strings":["Department of Hematology (H.C.H.), Odense University Hospital, 5000 Odense, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology (H.C.H.), Odense University Hospital, 5000 Odense, Denmark","institution_ids":["https://openalex.org/I2801498763"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039528393","display_name":"L\u00e1szl\u00f3 D\u00e1vid Heged\u0171s","orcid":"https://orcid.org/0000-0002-9691-7619","observed_orcids":["https://orcid.org/0000-0002-9691-7619"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801498763"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Laszlo Hegedu\u0308s","raw_affiliation_strings":["Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism (D.E.F., S.J.B., L.H.), Odense University Hospital, 5000 Odense, Denmark","institution_ids":["https://openalex.org/I2801498763"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039528393"],"corresponding_institution_ids":["https://openalex.org/I2801498763"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":10.0468,"has_fulltext":true,"cited_by_count":166,"citation_normalized_percentile":{"value":0.98541854,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"92","issue":"5","first_page":"1769","last_page":"1772"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11538","display_name":"Ophthalmology and Eye Disorders","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/graves-disease","display_name":"Graves' disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9240000247955322},{"id":"https://openalex.org/keywords/tsh-receptor-antibodies","display_name":"TSH receptor antibodies","score":0.949999988079071},{"id":"https://openalex.org/keywords/hyperthyroidism-relapse","display_name":"hyperthyroidism relapse","score":0.921999990940094},{"id":"https://openalex.org/keywords/methimazole","display_name":"methimazole","score":0.8270000219345093},{"id":"https://openalex.org/keywords/glucocorticoids","display_name":"glucocorticoids","score":0.8429999947547913},{"id":"https://openalex.org/keywords/autoimmune-thyroid-disease","display_name":"autoimmune thyroid disease","score":0.6470000147819519}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.794914960861206},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7870419025421143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6754909753799438},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6273253560066223},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5977988839149475},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5199462175369263},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4619735777378082},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4577469229698181},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4357394874095917},{"id":"https://openalex.org/C2776652619","wikidata":"https://www.wikidata.org/wiki/Q16483","display_name":"Graves' disease","level":3,"score":0.4204157888889313},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26563596725463867},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006111","descriptor_name":"Graves Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007453","descriptor_name":"Iodide Peroxidase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008713","descriptor_name":"Methimazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011989","descriptor_name":"Receptors, Thyrotropin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013956","descriptor_name":"Antithyroid Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013963","descriptor_name":"Thyroid Hormones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D049970","descriptor_name":"Graves Ophthalmopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1210/jc.2006-2388","doi":"https://doi.org/10.1210/jc.2006-2388","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2006-2388","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:17284622","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17284622","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/51cd83b0-cb44-11dc-8674-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/51cd83b0-cb44-11dc-8674-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"El Fassi, D, Nielsen, C H, Bonnema, S J, Hasselbalch, H C & Heged\u00fcs, L 2007, 'B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study', The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 5, pp. 1769-1772. https://doi.org/10.1210/jc.2006-2388","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b4c5f2b8-b975-4555-a2ea-719d23e4b71b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/b4c5f2b8-b975-4555-a2ea-719d23e4b71b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"El Fassi, D, Nielsen, C H, Bonnema, S J, Hasselbalch, H K & Heged\u00fcs, L 2007, 'B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study', Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 5, pp. 1769-72. https://doi.org/10.1210/jc.2006-2388","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2182042052","doi":null,"is_oa":false,"landing_page_url":"http://www.med.tottori-u.ac.jp/system/site/upload/deci/2861/atc_1255980231.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320322441","display_name":"Odense Universitetshospital","ror":"https://ror.org/00ey0ed83"},{"id":"https://openalex.org/F4320323799","display_name":"Syddansk Universitet","ror":"https://ror.org/03yrrjy16"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1968889356","https://openalex.org/W1984186890","https://openalex.org/W1991300758","https://openalex.org/W1995386393","https://openalex.org/W1998618256","https://openalex.org/W2042172469","https://openalex.org/W2077158310","https://openalex.org/W2085313965","https://openalex.org/W2100151922","https://openalex.org/W2105413437","https://openalex.org/W2107642899","https://openalex.org/W2114302659","https://openalex.org/W2115263908","https://openalex.org/W2125627178","https://openalex.org/W2130748121","https://openalex.org/W2139784595","https://openalex.org/W2151464162","https://openalex.org/W2164819810","https://openalex.org/W4241821218","https://openalex.org/W4243225672","https://openalex.org/W6642398217","https://openalex.org/W6677202855","https://openalex.org/W6684253913"],"related_works":["https://openalex.org/W2145253402","https://openalex.org/W2110391738","https://openalex.org/W2157437551","https://openalex.org/W2143632658","https://openalex.org/W7098007137","https://openalex.org/W2125627178","https://openalex.org/W2101727625","https://openalex.org/W1530237942","https://openalex.org/W4403638249"],"abstract_inverted_index":{"CONTEXT:":[0],"Graves'":[1],"disease":[2],"(GD)":[3],"is":[4],"a":[5,66,93,160,230],"common":[6],"TSH":[7],"receptor":[8],"autoantibody":[9,147,227,267],"(TRAb)-mediated":[10],"disorder.":[11],"Because":[12],"B":[13],"lymphocytes":[14],"are":[15],"important":[16],"self-antigen":[17],"presenting":[18],"cells":[19],"and":[20,99,121,123,144,269,284],"precursors":[21],"for":[22,92,241],"antibody-secreting":[23],"plasma":[24],"cells,":[25],"temporary":[26],"B-lymphocyte":[27],"depletion":[28],"with":[29,69,73,159,211,256,258,274],"the":[30,53,104,108,153,171,174,187,204,208],"monoclonal":[31],"antibody":[32],"rituximab":[33],"(RTX)":[34],"might":[35],"be":[36],"of":[37,44,55,95,142,163,186,203],"benefit":[38],"in":[39,57,107,146,152,157,173,189,207,217,254,272,292],"GD.":[40,58,76,294],"OBJECTIVE/DESIGN:":[41],"The":[42,87],"objective":[43],"this":[45],"prospective,":[46],"controlled,":[47],"nonrandomized":[48],"study":[49],"was":[50],"to":[51,65,140,229],"investigate":[52],"effect":[54],"RTX":[56,79,222,245,248,263],"SETTING/PATIENTS:":[59],"We":[60,137],"studied":[61],"20":[62],"outpatients":[63],"referred":[64],"university":[67],"clinic":[68],"newly":[70],"diagnosed":[71],"(four":[72],"relapse)":[74],"untreated":[75],"Ten":[77],"received":[78,89,111,239],"(+RTX),":[80],"whereas":[81,169],"10":[82],"did":[83,224,234,264],"not":[84,225,265,289],"(-RTX).":[85],"INTERVENTION:":[86],"patients":[88,125,151,172,188,206,238,255,273],"methimazole":[90,129],"(MMI)":[91,130],"median":[94,161],"102":[96],"d":[97,101,117,132,165,180],"(+RTX)":[98],"110":[100],"(-RTX)":[102],"before":[103],"study.":[105],"Patients":[106],"+RTX":[109,154],"group":[110,155,176,210],"375":[112],"mg":[113],"RTX/m(2)":[114],"iv":[115],"on":[116],"1,":[118],"8,":[119],"15,":[120],"22,":[122],"all":[124,170],"were":[126,216],"withdrawn":[127],"from":[128],"at":[131],"22.":[133],"MAIN":[134],"OUTCOME":[135],"MEASURES:":[136],"measured":[138],"time":[139],"relapse":[141],"hyperthyroidism":[143],"changes":[145],"levels.":[148,261,277],"RESULTS:":[149],"Four":[150],"remained":[156],"remission":[158,190,218,253],"follow-up":[162],"705":[164],"(range,":[166],"435-904":[167],"d),":[168],"-RTX":[175,209],"had":[177,191],"relapsed":[178],"by":[179],"393":[181],"(P":[182,219],"<":[183,220],"0.05).":[184],"All":[185],"initial":[192],"TRAb":[193,214,260,276],"levels":[194,215,228,268],"below":[195],"5":[196],"IU/liter":[197],"(normal,":[198],"<0.7":[199],"IU/liter).":[200],"However,":[201,262],"none":[202],"five":[205],"correspondingly":[212],"low":[213,259,282],"0.01).":[221],"treatment":[223,249],"affect":[226,266],"greater":[231],"extent":[232],"than":[233],"MMI":[235],"monotherapy.":[236],"Two":[237],"glucocorticoids":[240],"joint":[242],"pain":[243],"after":[244],"therapy.":[246],"CONCLUSIONS:":[247],"may":[250],"induce":[251],"sustained":[252],"GD":[257],"seems":[270],"ineffective":[271],"high":[275,280],"At":[278],"present,":[279],"cost,":[281],"efficacy,":[283],"potential":[285],"side":[286],"effects":[287],"do":[288],"support":[290],"use":[291],"uncomplicated":[293]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005305700","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
